FDA Changes Policy, Allows Abortion Pills To Be Sent Through Mail During COVID-19 Pandemic

The U.S. Food and Drug Administration announced on Monday that it will change its policy regarding the access of abortion pills through the use of telemedicine.

In the latest development of a continuing legal debate over the use of telemedicine for chemical abortion, the FDA sent a letter to the American College of Obstetricians and Gynecologists (ACOG) announcing its decision to allow abortion pills to be sent through the mail and prescribed via telemedicine during the COVID-19 health emergency.